Reproducible production of stable recombinant proteins is essential for biochemical and structural studies, but conventional optimization may be insufficient when constrained by protein-specific requirements.In this study, we investigated batch-to-batch variation in the recombinant production of a putative Zn 2+ -dependent metalloprotease from Cutibacterium acnes.Protein expression and purification yields varied despite identical procedures, and conventional optimization failed to restore consistency.AlphaFold2 modeling and comparison with a Zn 2+ -bound homolog suggested a conserved Zn 2+ -binding site.Protein production was therefore compared between cultures grown with and without Zn 2+ supplementation.The Zn 2+ -supplemented batch exhibited a stronger target-protein band on SDS-PAGE and a larger A 280 peak on size-exclusion chromatography, indicating greater protein recovery.Under identical crystallization conditions, the unsupplemented protein predominantly formed microcrystals of approximately 50 μm, whereas the Zn 2+ -supplemented protein formed larger crystals of approximately 300-500 μm.These findings associate Zn 2+ supplementation with increased protein recovery and larger crystal formation, highlighting the importance of considering protein-specific cofactor requirements during recombinant protein production.
No takes yet. Share an insight, caveat, or question.
Hyo Jung Kim (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: